Literature DB >> 3840789

Metabolic products of microorganisms. 225. Elloramycin, a new anthracycline-like antibiotic from Streptomyces olivaceus. Isolation, characterization, structure and biological properties.

H Drautz, P Reuschenbach, H Zähner, J Rohr, A Zeeck.   

Abstract

Elloramycin (1), a new antibiotic produced by Streptomyces olivaceus strain Tü 2353, was detected by chemical screening. The dark yellow compound, molecular formula C32H36O15, is weakly active against a variety of Gram-positive bacteria, especially streptomycetes and against stem cells of L-1210 leukemia. Acidic hydrolysis of the antibiotic liberated elloramycinone (3) as aglycone and 2,3,4-tri-O-methyl-L-rhamnose, which was identified as methyl glycoside 5b. The structure of elloramycin was established by comparison of the spectra (UV, 1H NMR, 13C NMR) with those of the known tetracenomycin C (2), 3 and the fact that 2 and 3 gave the same tetramethyl ether after permethylation. Elloramycin is an anthracycline-like antibiotic, the aglycone resembles tetracenomycin C, the sugar is connected in a phenolic alpha-glycosidic linkage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840789     DOI: 10.7164/antibiotics.38.1291

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Ketoolivosyl-tetracenomycin C: a new ketosugar bearing tetracenomycin reveals new insight into the substrate flexibility of glycosyltransferase ElmGT.

Authors:  S Eric Nybo; Khaled A Shabaan; Madan K Kharel; Happy Sutardjo; José A Salas; Carmen Méndez; Jürgen Rohr
Journal:  Bioorg Med Chem Lett       Date:  2012-02-03       Impact factor: 2.823

3.  A BioBricks toolbox for metabolic engineering of the tetracenomycin pathway.

Authors:  Jennifer T Nguyen; Kennedy K Riebschleger; Katelyn V Brown; Nina M Gorgijevska; S Eric Nybo
Journal:  Biotechnol J       Date:  2021-11-12       Impact factor: 4.677

4.  Pathway Engineering of Anthracyclines: Blazing Trails in Natural Product Glycodiversification.

Authors:  Katelyn V Brown; Benjamin Nji Wandi; Mikko Metsä-Ketelä; S Eric Nybo
Journal:  J Org Chem       Date:  2020-09-22       Impact factor: 4.354

5.  Anthracycline metabolites of tetracenomycin C-nonproducing Streptomyces glaucescens mutants.

Authors:  S Yue; H Motamedi; E Wendt-Pienkowski; C R Hutchinson
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

6.  Novel aromatic polyketides from soil Streptomyces spp.: purification, characterization and bioactivity studies.

Authors:  Sunita Bundale; Deovrat Begde; Dhanashree Pillai; Karishma Gangwani; Nandita Nashikkar; Tukaram Kadam; Avinash Upadhyay
Journal:  World J Microbiol Biotechnol       Date:  2018-04-24       Impact factor: 3.312

7.  Heterologous expression of 8-demethyl-tetracenomycin (8-dmtc) affected Streptomyces coelicolor life cycle.

Authors:  Buse Cinar; Zeynep Demir; Sedef Tunca
Journal:  Braz J Microbiol       Date:  2021-04-20       Impact factor: 2.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.